目录号: | BY00021 |
产品名称: | 卡博替尼 |
英文名: | Cabozantinib(XL184) |
别名: | [14C]-Cabozantinib; Cabozantinib; cyclopropane- 1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide; cyclopropane-1,1-dicarboxylicacid [4-(6,7-dimethoxy-quinoline-4-yloxy)phenyl]amide(4-fluorophenyl)amide; cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxyquinoline-4-yloxy)phenyl]amide(4-fluorophenyl)amide; Cometriq?; cabozantinib |
IUPAC Name: | 1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1- N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
CAS号: | 849217-68-1 |
分子式: | C28H24FN3O5 |
分子量: | 502 |
纯度: | 99%+ |
供应能力: | 克到公斤级 |
参考信息 | |
InChI Key: | ONIQOQHATWINJY-UHFFFAOYSA-N |
Reaxys Registry Number: | 18631644 |
Pub CID: | 25102847 |
Canonical SMILES: | COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O) NC5=CC=C(C=C5)F |
References: | Article; She, Nengfang; Zhuo, Linsheng; Jiang, Wen; Zhu, Xiaolei; Wang, Jia; Ming, Zhihui; Zhao, Xinge; Cong, Xin; Huang, Wei; Bioorganic and Medicinal Chemistry Letters; vol. 24; 15; (2014); p. 3351 - 3355; Patent; EXELIXIS, INC.; SWEENEY, Christopher J.; KANTOFF, Philip W.; WO2014/165779; (2014); A1; Article; Jiang, Xiaolong; Liu, Hongyan; Song, Zilan; Peng, Xia; Ji, Yinchun; Yao, Qizheng; Geng, Meiyu; Ai, Jing; Zhang, Ao; Bioorganic and Medicinal Chemistry; vol. 23; 3; (2015); p. 564 - 578; Patent; EXELIXIS, INC.; AFTAB, Dana, T; SCHIMMOLLER, Frauke; WO2013/70890; (2013); A1; Patent; EXELIXIS, INC.; AFTAB, Dana, T.; WO2013/166296; (2013); A1; Patent; EXELIXIS, INC.; DECILLIS, Arthur; WO2014/165786; (2014); A1; Patent; EXELIXIS, INC.; AFTAB, Dana, T.; NAGANATHAN, Sriram; XU, Wei; LACY, Steven; NGUYEN, Linh; WO2014/145715; (2014); A1; Patent; EXELIXIS, INC.; WILSON, Jo, Ann; NAGANATHAN, Sriram; PFEIFFER, Matthew; ANDERSEN, Neil, G.; WO2013/59788; (2013); A1; Patent; EXELIXIS, INC.; AFTAB, Dana, T.; CLARY, Douglas; WO2013/43840; (2013); A1; Patent; EXELIXIS, INC.; WILSON, Jo Ann; WO2012/109510; (2012); A1; |